Over 10 Total Lots Up For Auction at One Location - CO 06/17

Novian Health obtains CE Mark for Novilase Breast Therapy

Press releases may be edited for formatting or style | July 16, 2019 Women's Health

In addition to obtaining the CE Mark approval, Novian Health also received ISO:13485:2016 certification for its quality management system. To earn the certification, Novian had to demonstrate its ability to provide its products and related services in a way that consistently meets customer and applicable regulatory requirements.

Breast tumors, both cancerous and non-cancerous, are one of the most serious health problems facing women today. Breast cancer is the most common cancer in women worldwide, with an annual incidence of 404,920 in the EU. More than two-thirds of newly diagnosed breast cancers are found when tumors are smaller than 2 cm.

stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

Fibroadenomas are the most common type of solid breast tumor (typically benign), affecting an estimated 10 percent of all women.

About Novian Health Inc.
Based in Chicago, with a subsidiary in Evry, France, Novian Health Inc. is a privately held medical device company with proprietary technology for the treatment of tumors using Interstitial Laser Therapy. For more information, call (312) 266-7200 or access www.novianhealth.com.

Contact: Liz Dowling, Phone (415) 388-2794
Dowling & Dennis Public Relations
Email: liz@dowlingdennis.net

SOURCE Novian Health

Back to HCB News

You Must Be Logged In To Post A Comment